POTI', Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.829
EU - Europa 1.483
AS - Asia 651
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
Totale 3.984
Nazione #
US - Stati Uniti d'America 1.805
CN - Cina 423
IT - Italia 366
IE - Irlanda 315
SE - Svezia 237
FI - Finlandia 196
DE - Germania 135
SG - Singapore 135
UA - Ucraina 121
TR - Turchia 72
AT - Austria 33
CA - Canada 24
GB - Regno Unito 17
BE - Belgio 15
CZ - Repubblica Ceca 12
FR - Francia 12
IN - India 10
NL - Olanda 9
CI - Costa d'Avorio 8
EU - Europa 7
CL - Cile 4
HK - Hong Kong 4
PL - Polonia 4
RO - Romania 4
BG - Bulgaria 3
ES - Italia 2
IR - Iran 2
KZ - Kazakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CO - Colombia 1
GR - Grecia 1
HU - Ungheria 1
Totale 3.984
Città #
Chandler 349
Dublin 315
Ann Arbor 145
Jacksonville 140
Dearborn 108
Ashburn 104
Beijing 99
Boardman 95
Singapore 95
Parma 87
Houston 83
Princeton 73
New York 70
Izmir 67
Nanjing 63
Wilmington 52
Chicago 40
Shanghai 33
San Mateo 31
Vienna 31
Helsinki 29
Bremen 27
Nanchang 24
Des Moines 23
Toronto 21
Hebei 20
Rho 20
Shenyang 20
Jinan 18
Milan 18
Seattle 17
Brussels 15
Hefei 15
Jiaxing 15
Fremont 14
Santa Clara 11
Bologna 10
Brno 10
Changsha 10
Fairfield 10
Guangzhou 10
Kunming 10
Tianjin 9
Abidjan 8
Washington 8
Grafing 7
Zhengzhou 7
Chengdu 6
Rockville 6
Düsseldorf 5
Faenza 5
Hangzhou 5
Modena 5
Pune 5
Taiyuan 5
Woodbridge 5
Borås 4
Dallas 4
Los Angeles 4
Naples 4
Norwalk 4
Segrate 4
Verona 4
Vigevano 4
Amsterdam 3
Ancona 3
Bergamo 3
Casièr 3
Crotone 3
Edinburgh 3
Formigine 3
Frankfurt am Main 3
Fuzhou 3
Huizen 3
Kocaeli 3
Leawood 3
Leipzig 3
London 3
Ningbo 3
Paris 3
Piacenza 3
Pisa 3
Reggio Emilia 3
Rome 3
San Giuliano Milanese 3
Shaoxing 3
Sofia 3
Almaty 2
Ardea 2
Augusta 2
Brescia 2
Brooklyn 2
Cagliari 2
Caorso 2
Drò 2
Fiorenzuola d'Arda 2
Haikou 2
Istanbul 2
Kansas City 2
Lonato 2
Totale 2.660
Nome #
Treatments for COVID-19: emerging drugs against the coronavirus 159
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 149
Effects of the radiocontrast agent iodixanol on endothelial cell morphology and function. 109
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 101
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies 92
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 88
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 87
EFFETTI DEI MEZZI DI CONTRASTO E DELLA N-ACETILCISTEINA SU MORFOLOGIA E FUNZIONE DELLE CELLULE ENDOTELIALI UMANE 80
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 78
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 77
Critical and emerging topics in dietary carbohydrates and health 73
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 72
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 72
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 70
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 69
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 68
'Spare' Luteinizing Hormone Receptors: Facts and Fiction 66
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 66
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 66
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 64
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 64
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 63
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 63
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 63
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 62
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 62
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 59
Impact of apolipoprotein E (apoE) deficiency on reverse cholesterol transport in vivo 56
The liver-X-receptor agonist T0901317 stimulates in vivo reverse cholesterol transport in mice 55
Meccanismo di attivazione dell’ATP-binding cassette A1 da parte del cAMP 55
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 55
Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions 55
ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN VIVO 54
Effect of LXR agonists on reverse cholesterol transport in vivo 54
Drug-drug interactions in polypharmacy patients: The impact of renal impairment 54
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 53
IN VIVO TREATMENT WITH CYCLOSPORINE A INCREASES EFFLUX POTENTIAL OF MOUSE PLASMA VIA ATP-BINDING CASSETTE TRANSPORTER ABCA1 52
The in vivo stimulation of LXR promotes the reverse cholesterol transport in vivo by increasing the efflux potential of sera 51
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 51
Pharmacogenetics of GPCR variants: FSH receptor and infertility treatment 48
Effect of the LXR agonist T0901317 on reverse cholesterol transport in vivo 47
Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP 47
Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity 45
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 45
The LXR agonist T0901317 increases the efflux potential of sera and promotes the reverse cholesterol transport in mice 44
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) 43
In vivo stimulation of LXR increases the efflux potential of sera and promotes the reverse cholesterol transport 42
La rosuvastatina promuove il trasporto inverso del colesterolo nei topi 42
Aortic Gene Expression Profiles Show How ApoA-I Levels Modulate Inflammation, Lysosomal Activity, and Sphingolipid Metabolism in Murine Atherosclerosis 42
Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis 41
Sphingosine-1 phosphate induces cAMP/PKA-independent phosphorylation of the cAMP response element-binding protein (CREB) in granulosa cells 41
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 41
Il cAMP attiva l’ATP-Binding Cassette A1 (ABCA1) attraverso un duplice meccanismo 39
Sphingosine 1-Phosphate (S1P): a bridge between HDL, inflammation and atherosclerosis? 39
Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice 39
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice 39
SKI-II - a sphingosine kinase 1 inhibitor - exacerbates atherosclerosisin low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet 35
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 33
Sphingolipids and atherosclerosis: focus on Sphingosine 1-Phosphate (S1P) 33
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R-/-) mice 32
Glycosylation pattern and in vitro bioactivity of reference follitropin alfa and biosimilars 32
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/-mice 32
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein 32
Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro 29
Identification of sclerostin as a putative new myokine involved in the muscle-to-bone crosstalk 29
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R -/-) mice 28
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression 26
Osteocytes specific GSK3 inhibition affects in vitro osteogenic differentiation 25
Molecular basis of androgen action on human sexual desire 24
Seizures of illicit substances for personal use in two Italian provinces: Analysis of trends by type and purity from 2008 to 2017 24
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro 23
The “hitchhiker’s guide to the galaxy” of endothelial dysfunction markers in human fertility 23
COVID-19 … What are drugs and strategies now? 22
Gnrh antagonists produce differential modulation of the signaling pathways mediated by gnrh receptors 22
Treatments for COVID-19: Emerging drugs against the coronavirus-reply 22
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 19
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 18
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways 2
Editorial: Pharmacology of endocrine related GPCRs 2
Totale 4.078
Categoria #
all - tutte 16.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020543 0 0 29 7 53 161 86 22 61 52 33 39
2020/2021448 4 32 28 14 61 57 39 14 73 12 85 29
2021/2022399 21 15 16 9 25 18 65 54 20 27 6 123
2022/20231.260 140 100 79 114 131 147 13 89 380 14 41 12
2023/2024557 23 42 13 21 26 140 31 54 19 34 45 109
2024/2025244 46 88 110 0 0 0 0 0 0 0 0 0
Totale 4.078